The Board of Directors of Dr Lal PathLabs Ltd will consider issuing bonus shares and an interim dividend on October 31, signalling confidence in the business ahead of second-quarter results, the diagnostic major announced in an exchange filing on Friday.

"This is to inform you that a meeting of the Board of Directors is scheduled to be held on Friday, October 31, 2025 to inter alia:

1. Consider and approve Un-audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Half Year ended September 30, 2025;

2. Consider declaration of 2nd Interim Dividend, if any, on the Equity Shares of the Company for the Financial Year 2025-26; &

3. Consider issuance of bonus shares in accordance with the applicable provisions and subject to approval of Shareholders of the

See Full Page